Noida, UP -- (SBWire) -- 06/24/2014 --Significant advancements in the past few years have fuelled interest again in ADCs. These advancements include improvements in linking technologies, which has helped in the development of drugs such as Adcetris and Kadcyla. PolyTherics has also come up with ThioBridge conjugation and linker technology.
Preclinical studies with precise linking technologies, such as those with Genentech’s ThioMab technology have already shown that the therapeutic index, the ratio between efficacy and tolerability, can be improved. As evident from the above developments, efficacy and tolerability of ADCs will improve as control over its design is achieved, thereby fuelling interest in these smart bombs.
Research Analysis & Highlights
According to our report, “Global Antibody Drug Conjugate Market Outlook 2018”, backed by improved understanding and better technology, the ADC market is anticipated to reach US$ 3.45 Billion by 2018. Our report analyzes the market for Adcetris and Kadcyla in detail. Market potential for these drugs has been estimated keeping in mind the fact that these drugs are being tested in clinical trials for various indications apart from the ones for which they are approved.
The report also provides an insight into the key ADCs that are currently in pipeline. Apart from new drug candidates, previously approved drugs are also being tested for other indications. Later in the report, strategic activities such as mergers, acquisitions and collaborations that have taken place over ADC have been provided.
At the end, major players of ADC market have been discussed. A brief business overview of every player has been provided alongwith their product and pipeline portfolio and recent developments. A comparative strength and weakness analysis of these players has been done. Overall, the report will prove to be a complete source of knowledge and analysis for clients and potential investors.
Some of the key findings of the report are:
- Strong pipeline to be a major influence for the Global ADC Market
- Efforts towards patent protection to Drive ADC Market
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM667.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
ABOUT RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.
Advances in Linking Technologies Bring Back ADCs
According to RNCOS, “Improvements in linking technologies will enhance the efficacy and tolerability of ADCs and drive the market which is expected to reach US$ 3.45 Billion by 2018”.